Live market news
Stocks
IKT

Inhibikase Therapeutics Inc

IKTStockUSA

See in Charts

Latest news on IKTranked by Oyticker for market impact

15Impact
Neutral2 Oct 2026 · 20:01 UTC · Global · Medium term
IKT grants 128k stock options to new hires under Nasdaq inducement rule
Inhibikase Therapeutics granted non-qualified stock options for 128,000 shares to two newly-hired non-executive employees as hiring incentives under Nasdaq Rule 5635(c)(4), effective September 30, 2026.
IKTBiotechnology

SEC filings

What IKT filed

All its filings

10 Nov 2026
Quarterly report (opens the document on sec.gov)10-Q
10 Nov 2026
Results announced (opens the document on sec.gov)8-K
20 Oct 2026
Executive or director change (opens the document on sec.gov)8-K
Investor communication
8 Sept 2026
Investor communication (opens the document on sec.gov)8-K
26 Aug 2026
Change of auditor (opens the document on sec.gov)8-K
11 Aug 2026
Quarterly report (opens the document on sec.gov)10-Q
11 Aug 2026
Results announced (opens the document on sec.gov)8-K
29 Jul 2026
Unregistered share sale (opens the document on sec.gov)8-K
23 Jul 2026
Investor communication (opens the document on sec.gov)8-K
14 Jul 2026
Other event (opens the document on sec.gov)8-K
29 Jun 2026
Executive or director change (opens the document on sec.gov)8-K
Shareholder vote results · Bylaws or fiscal year changed
12 May 2026
Quarterly report (opens the document on sec.gov)10-Q
12 May 2026
Results announced (opens the document on sec.gov)8-K

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.

Latest news on IKTranked by Oyticker for market impact

IKT grants 128k stock options to new hires under Nasdaq inducement rule

What IKT filed